These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2695309)

  • 1. Different mast cell mediators produced by different mast cell phenotypes.
    Gurish MF; Austen KF
    Ciba Found Symp; 1989; 147():36-45; discussion 45-52. PubMed ID: 2695309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the fibroblast environment on the structure of mast cell proteoglycans.
    Rothenberg ME; Austen KF
    Ann N Y Acad Sci; 1989; 556():233-44. PubMed ID: 2660686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distorted secretory granule composition in mast cells with multiple protease deficiency.
    Grujic M; Calounova G; Eriksson I; Feyerabend T; Rodewald HR; Tchougounova E; Kjellén L; Pejler G
    J Immunol; 2013 Oct; 191(7):3931-8. PubMed ID: 23975861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological implications of preformed mast cell mediators.
    Lundequist A; Pejler G
    Cell Mol Life Sci; 2011 Mar; 68(6):965-75. PubMed ID: 21069421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for cathepsin E in the processing of mast-cell carboxypeptidase A.
    Henningsson F; Yamamoto K; Saftig P; Reinheckel T; Peters C; Knight SD; Pejler G
    J Cell Sci; 2005 May; 118(Pt 9):2035-42. PubMed ID: 15860733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction with dithiothreitol causes serglycin-specific defects in secretory granule integrity of bone marrow derived mast cells.
    Braga T; Ringvall M; Tveit H; Abrink M; Pejler G
    Mol Immunol; 2009 Jan; 46(3):422-8. PubMed ID: 19059647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
    Stevens RL; Adachi R
    Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM; Leong J; Schwartz LB; Cooke D
    J Immunol; 1992 Apr; 148(8):2475-82. PubMed ID: 1560203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
    Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
    J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell proteoglycans.
    Rönnberg E; Melo FR; Pejler G
    J Histochem Cytochem; 2012 Dec; 60(12):950-62. PubMed ID: 22899859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/Wv mice that are genetically deficient in mast cells.
    Otsu K; Nakano T; Kanakura Y; Asai H; Katz HR; Austen KF; Stevens RL; Galli SJ; Kitamura Y
    J Exp Med; 1987 Mar; 165(3):615-27. PubMed ID: 3102674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components.
    Henningsson F; Hergeth S; Cortelius R; Abrink M; Pejler G
    FEBS J; 2006 Nov; 273(21):4901-12. PubMed ID: 17010166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serglycin-independent release of active mast cell proteases in response to Toxoplasma gondii infection.
    Sawesi O; Spillmann D; Lundén A; Wernersson S; Åbrink M
    J Biol Chem; 2010 Dec; 285(49):38005-13. PubMed ID: 20864536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker.
    Serafin WE; Dayton ET; Gravallese PM; Austen KF; Stevens RL
    J Immunol; 1987 Dec; 139(11):3771-6. PubMed ID: 3680950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine mRNA are preferentially increased relative to secretory granule protein mRNA in mouse bone marrow-derived mast cells that have undergone IgE-mediated activation and degranulation.
    Gurish MF; Ghildyal N; Arm J; Austen KF; Avraham S; Reynolds D; Stevens RL
    J Immunol; 1991 Mar; 146(5):1527-33. PubMed ID: 1993842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells.
    Atiakshin D; Kostin A; Trotsenko I; Samoilova V; Buchwalow I; Tiemann M
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand.
    Gurish MF; Ghildyal N; McNeil HP; Austen KF; Gillis S; Stevens RL
    J Exp Med; 1992 Apr; 175(4):1003-12. PubMed ID: 1372640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.
    Melo FR; Waern I; Rönnberg E; Åbrink M; Lee DM; Schlenner SM; Feyerabend TB; Rodewald HR; Turk B; Wernersson S; Pejler G
    J Biol Chem; 2011 Feb; 286(7):5423-33. PubMed ID: 21123167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases.
    Pejler G; Abrink M; Wernersson S
    Biofactors; 2009; 35(1):61-8. PubMed ID: 19319847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.